Cargando…

Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy

BACKGROUND: It has been hypothesized that reduced axonal transport contributes to the degeneration of neuronal processes in Parkinson's disease (PD). Mitochondria supply the adenosine triphosphate (ATP) needed to support axonal transport and contribute to many other cellular functions essential...

Descripción completa

Detalles Bibliográficos
Autores principales: Trimmer, Patricia A, Schwartz, Kathleen M, Borland, M Kathleen, De Taboada, Luis, Streeter, Jackson, Oron, Uri
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711937/
https://www.ncbi.nlm.nih.gov/pubmed/19534794
http://dx.doi.org/10.1186/1750-1326-4-26
_version_ 1782169462358671360
author Trimmer, Patricia A
Schwartz, Kathleen M
Borland, M Kathleen
De Taboada, Luis
Streeter, Jackson
Oron, Uri
author_facet Trimmer, Patricia A
Schwartz, Kathleen M
Borland, M Kathleen
De Taboada, Luis
Streeter, Jackson
Oron, Uri
author_sort Trimmer, Patricia A
collection PubMed
description BACKGROUND: It has been hypothesized that reduced axonal transport contributes to the degeneration of neuronal processes in Parkinson's disease (PD). Mitochondria supply the adenosine triphosphate (ATP) needed to support axonal transport and contribute to many other cellular functions essential for the survival of neuronal cells. Furthermore, mitochondria in PD tissues are metabolically and functionally compromised. To address this hypothesis, we measured the velocity of mitochondrial movement in human transmitochondrial cybrid "cytoplasmic hybrid" neuronal cells bearing mitochondrial DNA from patients with sporadic PD and disease-free age-matched volunteer controls (CNT). The absorption of low level, near-infrared laser light by components of the mitochondrial electron transport chain (mtETC) enhances mitochondrial metabolism, stimulates oxidative phosphorylation and improves redox capacity. PD and CNT cybrid neuronal cells were exposed to near-infrared laser light to determine if the velocity of mitochondrial movement can be restored by low level light therapy (LLLT). Axonal transport of labeled mitochondria was documented by time lapse microscopy in dopaminergic PD and CNT cybrid neuronal cells before and after illumination with an 810 nm diode laser (50 mW/cm(2)) for 40 seconds. Oxygen utilization and assembly of mtETC complexes were also determined. RESULTS: The velocity of mitochondrial movement in PD cybrid neuronal cells (0.175 +/- 0.005 SEM) was significantly reduced (p < 0.02) compared to mitochondrial movement in disease free CNT cybrid neuronal cells (0.232 +/- 0.017 SEM). For two hours after LLLT, the average velocity of mitochondrial movement in PD cybrid neurites was significantly (p < 0.003) increased (to 0.224 +/- 0.02 SEM) and restored to levels comparable to CNT. Mitochondrial movement in CNT cybrid neurites was unaltered by LLLT (0.232 +/- 0.017 SEM). Assembly of complexes in the mtETC was reduced and oxygen utilization was altered in PD cybrid neuronal cells. PD cybrid neuronal cell lines with the most dysfunctional mtETC assembly and oxygen utilization profiles were least responsive to LLLT. CONCLUSION: The results from this study support our proposal that axonal transport is reduced in sporadic PD and that a single, brief treatment with near-infrared light can restore axonal transport to control levels. These results are the first demonstration that LLLT can increase axonal transport in model human dopaminergic neuronal cells and they suggest that LLLT could be developed as a novel treatment to improve neuronal function in patients with PD.
format Text
id pubmed-2711937
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27119372009-07-17 Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy Trimmer, Patricia A Schwartz, Kathleen M Borland, M Kathleen De Taboada, Luis Streeter, Jackson Oron, Uri Mol Neurodegener Research Article BACKGROUND: It has been hypothesized that reduced axonal transport contributes to the degeneration of neuronal processes in Parkinson's disease (PD). Mitochondria supply the adenosine triphosphate (ATP) needed to support axonal transport and contribute to many other cellular functions essential for the survival of neuronal cells. Furthermore, mitochondria in PD tissues are metabolically and functionally compromised. To address this hypothesis, we measured the velocity of mitochondrial movement in human transmitochondrial cybrid "cytoplasmic hybrid" neuronal cells bearing mitochondrial DNA from patients with sporadic PD and disease-free age-matched volunteer controls (CNT). The absorption of low level, near-infrared laser light by components of the mitochondrial electron transport chain (mtETC) enhances mitochondrial metabolism, stimulates oxidative phosphorylation and improves redox capacity. PD and CNT cybrid neuronal cells were exposed to near-infrared laser light to determine if the velocity of mitochondrial movement can be restored by low level light therapy (LLLT). Axonal transport of labeled mitochondria was documented by time lapse microscopy in dopaminergic PD and CNT cybrid neuronal cells before and after illumination with an 810 nm diode laser (50 mW/cm(2)) for 40 seconds. Oxygen utilization and assembly of mtETC complexes were also determined. RESULTS: The velocity of mitochondrial movement in PD cybrid neuronal cells (0.175 +/- 0.005 SEM) was significantly reduced (p < 0.02) compared to mitochondrial movement in disease free CNT cybrid neuronal cells (0.232 +/- 0.017 SEM). For two hours after LLLT, the average velocity of mitochondrial movement in PD cybrid neurites was significantly (p < 0.003) increased (to 0.224 +/- 0.02 SEM) and restored to levels comparable to CNT. Mitochondrial movement in CNT cybrid neurites was unaltered by LLLT (0.232 +/- 0.017 SEM). Assembly of complexes in the mtETC was reduced and oxygen utilization was altered in PD cybrid neuronal cells. PD cybrid neuronal cell lines with the most dysfunctional mtETC assembly and oxygen utilization profiles were least responsive to LLLT. CONCLUSION: The results from this study support our proposal that axonal transport is reduced in sporadic PD and that a single, brief treatment with near-infrared light can restore axonal transport to control levels. These results are the first demonstration that LLLT can increase axonal transport in model human dopaminergic neuronal cells and they suggest that LLLT could be developed as a novel treatment to improve neuronal function in patients with PD. BioMed Central 2009-06-17 /pmc/articles/PMC2711937/ /pubmed/19534794 http://dx.doi.org/10.1186/1750-1326-4-26 Text en Copyright © 2009 Trimmer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Trimmer, Patricia A
Schwartz, Kathleen M
Borland, M Kathleen
De Taboada, Luis
Streeter, Jackson
Oron, Uri
Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy
title Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy
title_full Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy
title_fullStr Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy
title_full_unstemmed Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy
title_short Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy
title_sort reduced axonal transport in parkinson's disease cybrid neurites is restored by light therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711937/
https://www.ncbi.nlm.nih.gov/pubmed/19534794
http://dx.doi.org/10.1186/1750-1326-4-26
work_keys_str_mv AT trimmerpatriciaa reducedaxonaltransportinparkinsonsdiseasecybridneuritesisrestoredbylighttherapy
AT schwartzkathleenm reducedaxonaltransportinparkinsonsdiseasecybridneuritesisrestoredbylighttherapy
AT borlandmkathleen reducedaxonaltransportinparkinsonsdiseasecybridneuritesisrestoredbylighttherapy
AT detaboadaluis reducedaxonaltransportinparkinsonsdiseasecybridneuritesisrestoredbylighttherapy
AT streeterjackson reducedaxonaltransportinparkinsonsdiseasecybridneuritesisrestoredbylighttherapy
AT oronuri reducedaxonaltransportinparkinsonsdiseasecybridneuritesisrestoredbylighttherapy